The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
US Definitions, Current Use, and FDA Stance on Use of Platelet-Rich Plasma in Sports Medicine
Open accessAbstract
With increased utilization of platelet-rich plasma (PRP), it is important for clinicians to understand the United States, the Food and Drug Administration (FDA) regulatory role and stance on PRP. Blood products such as PRP fall under the prevue of FDA's Center for Biologics Evaluation and Research (CBER). CBER is responsible for regulating human cells, tissues, and cellular and tissue-based products. The regulatory process for these products is described in the FDA's 21 CFR 1271 of the Code of Regulations. Under these regulations, certain products including blood products such as PRP are exempt and therefore do not follow the FDA's traditional regulatory pathway that includes animal studies and clinical trials. The 510(k) application is the pathway used to bring PRP preparation systems to the market. The 510(k) application allows devices that are "substantially equivalent" to a currently marketed device to come to the market. There are numerous PRP preparation systems on the market today with FDA clearance; however, nearly all of these systems have 510(k) clearance for producing platelet-rich preparations intended to be used to mix with bone graft materials to enhance bone graft handling properties in orthopedic practices. The use of PRP outside this setting, for example, an office injection, would be considered "off label." Clinicians are free to use a product off-label as long as certain responsibilities are met. Per CBER, when the intent is the practice of medicine, clinicians "have the responsibility to be well informed about the product, to base its use on firm scientific rationale and on sound medical evidence, and to maintain records of the product's use and effects." Finally, despite PRP being exempted, the language in 21 CFR 1271 has caused some recent concern over activated PRP; however to date, the FDA has not attempted to regulate activated PRP. Clinicians using activated PRP should be mindful of these concerns and continued to stay informed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Carofino, B., Chowaniec, D. M., McCarthy, M. B., Bradley, J. P., Delaronde, S., Beitzel, K., Cote, M. P., Arciero, R. A., & Mazzocca, A. D. (2012) · Arthroscopy · doi:10.1016/j.arthro.2011.09.013 · Cited by 147
Self-citation
Cited by
Bone grafts and biomaterials substitutes for bone defect repair: A review
Wang, W., & Yeung, K. W. K. (2017) · Bioactive Materials · doi:10.1016/j.bioactmat.2017.05.007 · Cited by 1,938
Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020
(2020) · doi:10.3390/ijms21207794 · Cited by 1,039
Intra-articular treatment options for knee osteoarthritis
Jones, I. A., Togashi, R., Wilson, M. L., Heckmann, N., & Vangsness, C. T. (2019) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0123-4 · Cited by 525
Cook, J. L., Smith, P. A., Bozynski, C. C., Kuroki, K., Cook, C. R., Stoker, A. M., & Pfeiffer, F. M. (2016) · Journal of Orthopaedic Research · doi:10.1002/jor.23054 · Cited by 91
Platelet-rich plasma in patients affected with Peyronie’s disease
Achraf, C., Abdelghani, P. A., & Jihad, P. E. A. (2023) · Arab Journal of Urology · doi:10.1080/2090598x.2022.2135284 · Cited by 16
Metadata
- Authors
- Beitzel, K., Allen, D., Apostolakos, J., Russell, R., McCarthy, M., Gallo, G., Cote, M., & Mazzocca, A.
- Venue
- Journal of Knee Surgery
- Publisher
- Georg Thieme Verlag KG
- Published
- 2014-09-30
- Volume
- 28
- Issue
- 01
- Pages
- 029-034
- ISSN
- 1538-8506 (ISSN-L)
- 1938-2480
- OpenAlex
- W2026277675
- Cited by
- 160
- References
- 1
- FWCI
- 8.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: US Definitions, Current Use, and FDA Stance on Use of Platelet-Rich Plasma in Sports Medicine. https://app.cochat.ai/papers/10.1055/s-0034-1390030
- The paper
- Beitzel, K., Allen, D., Apostolakos, J., Russell, R., McCarthy, M., Gallo, G., Cote, M., & Mazzocca, A. (2014). US Definitions, Current Use, and FDA Stance on Use of Platelet-Rich Plasma in Sports Medicine. Journal of Knee Surgery. https://doi.org/10.1055/s-0034-1390030
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.